We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
(-3.5%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$72.5M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$54.4M |
| 3 |
Blackstone
BX
|
+$44M |
| 4 |
Airbnb
ABNB
|
+$37.4M |
| 5 |
Everest Group
EG
|
+$30.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$57.8M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
+$39.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$23.8M |
| 4 |
iShares Global Infrastructure ETF
IGF
|
+$19.2M |
| 5 |
PDCE
PDC Energy, Inc.
PDCE
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.73% |
| 2 | Healthcare | 12.76% |
| 3 | Financials | 12.67% |
| 4 | Consumer Discretionary | 11.16% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
iShares MSCI Netherlands ETF
EWN
$637M
| $100K | ﹤0.01% |
2,638
| – | – |
|
3227
Workhorse Group
WKHS
$36.3M
| $100K | ﹤0.01% |
81
-1
| -1% | -$2.57K |
|
3228
Kodiak Sciences
KOD
$2.84B
| $98.6K | ﹤0.01% |
54,755
-1,819
| -3% | -$6.42K |
|
3229
Sanara MedTech
SMTI
$313M
| $97.3K | ﹤0.01% |
3,126
+209
| +7% | +$8.1K |
|
|
MOMO
3230
Hello Group
MOMO
$866M
| $97.3K | ﹤0.01% |
13,937
+1,486
| +12% | +$13.7K |
|
|
VIGL
3231
DELISTED
Vigil Neuroscience
VIGL
| $97.3K | ﹤0.01% |
18,048
+1,690
| +10% | +$11.7K |
|
|
HSHP
3232
Himalaya Shipping
HSHP
$748M
| $96.2K | ﹤0.01% |
19,926
-7,315
| -27% | -$39.2K |
|
3233
FTC Solar
FTCI
$44.9M
| $95.2K | ﹤0.01% |
7,439
-97
| -1% | -$2.35K |
|
3234
Vor Biopharma
VOR
$1.28B
| $95.2K | ﹤0.01% |
2,245
+114
| +5% | +$6.18K |
|
3235
Santander
BSBR
$43.5B
| $94.7K | ﹤0.01% |
18,451
-200
| -1% | -$1.13K |
|
3236
Sight Sciences
SGHT
$412M
| $93.8K | ﹤0.01% |
27,822
-304
| -1% | -$2K |
|
3237
Nuvectis Pharma
NVCT
$617M
| $93.7K | ﹤0.01% |
7,273
+495
| +7% | +$7.17K |
|
|
DDI
3238
DoubleDown Interactive
DDI
$588M
| $92.7K | ﹤0.01% |
10,975
| – | – |
|
3239
PrimeEnergy Resources
PNRG
$298M
| $92.4K | ﹤0.01% |
797
+53
| +7% | +$5.22K |
|
3240
Bank of Montreal
BMO
$127B
| $92.4K | ﹤0.01% |
1,095
+145
| +15% | +$12.7K |
|
3241
Harmony Gold Mining
HMY
$12.3B
| $92.3K | ﹤0.01% |
24,552
+1,060
| +5% | +$4.37K |
|
3242
Verrica Pharmaceuticals
VRCA
$87.3M
| $91K | ﹤0.01% |
2,343
+291
| +14% | +$14.8K |
|
3243
Acrivon Therapeutics
ACRV
$74M
| $90.6K | ﹤0.01% |
9,477
+491
| +5% | +$5.67K |
|
|
LBPH
3244
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $90K | ﹤0.01% |
16,186
+804
| +5% | +$5.18K |
|
|
IVAC
3245
DELISTED
Intevac Inc
IVAC
| $88.4K | ﹤0.01% |
28,426
+1,524
| +6% | +$5.28K |
|
3246
JFrog
FROG
$10.8B
| $88.1K | ﹤0.01% |
3,474
| – | – |
|
|
OKUR
3247
OnKure Therapeutics
OKUR
$168M
| $86.3K | ﹤0.01% |
1,133
+323
| +40% | +$22K |
|
3248
Pearson
PSO
$9.9B
| $86.1K | ﹤0.01% |
8,169
+400
| +5% | +$4.29K |
|
3249
CPI Card Group
PMTS
$320M
| $86.1K | ﹤0.01% |
4,647
+356
| +8% | +$7.59K |
|
|
CD
3250
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $85.9K | ﹤0.01% |
10,350
-260
| -2% | -$2.11K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2023 Portfolio in Review
As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
- RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
- RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
- RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
- RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.
Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.